寶尊電商(09991.HK)5,000萬美元入股愛點擊 訂戰略合作框架
寶尊電商-SW(09991.HK)公布,認購愛點擊64.93萬股B類新股,認購價1,720萬美元;及向愛點擊現有股東收購247.14萬股ADS(美國存托憑證),認購價3,280萬美元,禁售期180天。完成後,集團將擁有愛點擊發行在外總股本4%,佔其總投票權10%。
作為交易的一部份,雙方達成戰略合作框架協議。據此,集團將為品牌合作夥伴提供線上運營和基礎設施服務,包括效果廣告、線上店鋪運營、客戶服務、倉儲、物流及相關後臺系統;而愛點擊將為有意計劃在騰訊生態圈中建立電子商務基礎設施的客戶提供以SaaS為基礎的信息技術及系統解決方案。雙方期望在騰訊電商生態圈內共同開發一個私域流量平臺。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.